Aliases & Classifications for Endophthalmitis

MalaCards integrated aliases for Endophthalmitis:

Name: Endophthalmitis 12 59 55 44 15 73

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 59  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:4692
MeSH 44 D009877
NCIt 50 C34586
Orphanet 59 ORPHA199323
ICD10 via Orphanet 34 H44.0 H44.1
MESH via Orphanet 45 D009877
UMLS via Orphanet 74 C0014236
ICD10 33 H45.1
UMLS 73 C0014236

Summaries for Endophthalmitis

Disease Ontology : 12 A globe disease that is characterized by inflammation of the inside of the eye.

MalaCards based summary : Endophthalmitis is related to purulent endophthalmitis and corneal abscess, and has symptoms including redness or discharge of eye An important gene associated with Endophthalmitis is DEFB1 (Defensin Beta 1), and among its related pathways/superpathways are Development VEGF signaling via VEGFR2 - generic cascades and Fluid shear stress and atherosclerosis. The drugs Lidocaine and Hyaluronic acid have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and liver, and related phenotypes are hematopoietic system and immune system

Wikipedia : 76 Endophthalmitis is an inflammation of the interior of the eye. It is a possible complication of all... more...

Related Diseases for Endophthalmitis

Diseases in the Endophthalmitis family:

Chronic Endophthalmitis Acute Endophthalmitis

Diseases related to Endophthalmitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 174)
# Related Disease Score Top Affiliating Genes
1 purulent endophthalmitis 33.7 OPTN VEGFA
2 corneal abscess 30.2 DEFB1 PLG
3 macular retinal edema 30.0 ICAM1 VEGFA
4 neovascular glaucoma 29.8 OPTN VEGFA
5 vitreous detachment 29.8 PLG VEGFA
6 acute endophthalmitis 12.3
7 chronic endophthalmitis 12.2
8 phacoanaphylactic uveitis 11.3
9 heterophyiasis 10.6 ICAM1 SELE
10 lymphocytic vasculitis 10.6 ICAM1 SELE
11 mooren's ulcer 10.6 ICAM1 SELE
12 plummer's disease 10.6 ICAM1 SELE
13 hymenolepiasis 10.6 ICAM1 SELE
14 macrophage activation syndrome 10.6 HMGB1 PRF1
15 subendocardial myocardial infarction 10.6 ICAM1 SELE
16 actinic prurigo 10.6 ICAM1 SELE
17 cataract 10.6
18 rheumatoid vasculitis 10.6 ICAM1 SELE
19 osteonecrosis of the jaw 10.6 DEFB1 VEGFA
20 hypersensitivity reaction type iii disease 10.5 ICAM1 SELE
21 sympathetic ophthalmia 10.5
22 critical limb ischemia 10.5 SELE VEGFA
23 shwartzman phenomenon 10.5 ICAM1 SELE
24 localized scleroderma 10.5 DEFB1 SELE
25 cytomegalovirus infection 10.5 ICAM1 SELE
26 hydrocele 10.5 SELE VEGFA
27 plasmodium vivax malaria 10.4 ICAM1 SELE
28 cutaneous lupus erythematosus 10.3 ICAM1 SELE
29 chronic myocardial ischemia 10.3 PLG VEGFA
30 yemenite deaf-blind hypopigmentation syndrome 10.3 OPTN VEGFA
31 diabetic macular edema 10.3 ICAM1 VEGFA
32 pneumonia 10.3
33 retinal vascular occlusion 10.2 PLG VEGFA
34 retinitis 10.2
35 vitreous disease 10.2 PLG VEGFA
36 plague 10.2 PLG SELE
37 leukostasis 10.2 ICAM1 SELE VEGFA
38 uveitis 10.1
39 endotheliitis 10.1
40 hypopyon 10.1
41 meningitis 10.1
42 rubeosis iridis 10.1 PLG VEGFA
43 cellulitis 10.1
44 orbital cellulitis 10.0
45 scleritis 10.0
46 corneal ulcer 10.0
47 lens disease 10.0 OPTN VEGFA
48 degeneration of macula and posterior pole 10.0 PLG VEGFA
49 endocarditis 10.0
50 mycobacterium chelonae 10.0

Graphical network of the top 20 diseases related to Endophthalmitis:



Diseases related to Endophthalmitis

Symptoms & Phenotypes for Endophthalmitis

UMLS symptoms related to Endophthalmitis:


redness or discharge of eye

MGI Mouse Phenotypes related to Endophthalmitis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 hematopoietic system MP:0005397 9.7 PLG PRF1 SELE VEGFA CARD9 GON4L
2 immune system MP:0005387 9.56 PRF1 SELE VEGFA CARD9 GON4L ICAM1
3 neoplasm MP:0002006 9.02 PLG PRF1 VEGFA GON4L ICAM1

Drugs & Therapeutics for Endophthalmitis

Drugs for Endophthalmitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 204)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Lidocaine Approved, Vet_approved Phase 4,Not Applicable 137-58-6 3676
2
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 1,Phase 2 9004-61-9 53477741
3
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 347396-82-1 459903
4
Ephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 299-42-3 9294
5
Moxifloxacin Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 354812-41-2, 151096-09-2 152946
6
Cefazolin Approved Phase 4,Not Applicable 25953-19-9 656510 33255
7
Pseudoephedrine Approved Phase 4,Phase 3,Phase 2,Not Applicable 90-82-4 7028
8 Estradiol valerate Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 979-32-8
9
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 124-94-7 31307
10
Prednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 50-24-8 5755
11
Norgestimate Approved, Investigational Phase 4,Phase 2,Phase 3,Not Applicable 35189-28-7 6540478
12
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 50-28-2 5757
13
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2,Not Applicable 83-43-2 6741
14
Ethinyl Estradiol Approved Phase 4,Phase 2,Phase 3,Not Applicable 57-63-6 5991
15
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 216974-75-3
16
Polyestradiol phosphate Approved Phase 4,Phase 2,Phase 3,Not Applicable 28014-46-2
17
Ofloxacin Approved Phase 4,Not Applicable 82419-36-1 4583
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 22916-47-8 4189
19
Iodine Approved, Investigational Phase 4,Not Applicable 7553-56-2 807
20
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 1,Not Applicable 50-02-2 5743
21
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
22
Levofloxacin Approved, Investigational Phase 4,Not Applicable 100986-85-4 149096
23
Povidone-iodine Approved Phase 4,Not Applicable 25655-41-8
24
Povidone Approved Phase 4,Not Applicable 9003-39-8
25
Bromfenac Approved July 1997 Phase 4,Phase 3,Phase 2 91714-94-2 60726
26 triamcinolone acetonide Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
27 Prednisolone acetate Phase 4,Phase 1,Phase 2,Not Applicable
28 Analgesics Phase 4,Phase 3,Phase 2,Not Applicable
29 glucocorticoids Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
30 Respiratory System Agents Phase 4,Phase 3,Phase 2,Not Applicable
31 Central Nervous System Depressants Phase 4,Not Applicable
32 Methylprednisolone acetate Phase 4,Phase 1,Phase 2,Not Applicable
33 Methylprednisolone Hemisuccinate Phase 4,Phase 1,Phase 2,Not Applicable
34 Fluoroquinolones Phase 4,Phase 2,Phase 3,Not Applicable
35 Adjuvants, Immunologic Phase 4,Phase 1,Phase 2
36 Cephalosporins Phase 4
37 Gastrointestinal Agents Phase 4,Phase 3,Not Applicable
38 Nasal Decongestants Phase 4,Phase 3,Phase 2,Not Applicable
39 Sodium Channel Blockers Phase 4,Not Applicable
40 Neuroprotective Agents Phase 4,Not Applicable
41 Contraceptive Agents Phase 4,Phase 2,Phase 3,Not Applicable
42 Contraceptives, Oral Phase 4,Phase 2,Phase 3,Not Applicable
43 Contraceptives, Oral, Combined Phase 4,Phase 2,Phase 3,Not Applicable
44 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Not Applicable
45 Tetrahydrozoline Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable
46 Anesthetics Phase 4,Not Applicable
47 Topoisomerase Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable
48 Hormone Antagonists Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable,Early Phase 1
49 Norgestimate, ethinyl estradiol drug combination Phase 4,Phase 2,Phase 3,Not Applicable
50 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable

Interventional clinical trials:

(show top 50) (show all 145)
# Name Status NCT ID Phase Drugs
1 Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain Unknown status NCT02324166 Phase 4 Cefazolin;Lidocaine
2 Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections Unknown status NCT00690313 Phase 4 Vigamox
3 IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Unknown status NCT00744666 Phase 4 Prednisolone 1% topical eye drops
4 Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease Unknown status NCT01738243 Phase 4 Hyaluronic Acid Gel injection;Saline injection
5 Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis Completed NCT00398658 Phase 4 gentamycin and clindamycin
6 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4 Preoperative conjunctival irrigation with 5% or 1.25% PI
7 Comparative Study of Ologen Collagen Matrix Versus Mitomycin-C in Glaucoma Filtering Surgery Completed NCT01440751 Phase 4 Use of Mitomycin-C (MMC) in trabeculectomy
8 Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Completed NCT01739920 Phase 4
9 Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery Completed NCT00491049 Phase 4 0.5% levofloxacin eye drops
10 The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012) Completed NCT01668004 Phase 4
11 Aurolab Hydrophobic Foldable Intraocular Lens Study Completed NCT00449267 Phase 4
12 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
13 Evaluation of Macular Changes After Intracameral Moxifloxacin for Prevention of Endophthalmitis Recruiting NCT03363295 Phase 4 Moxifloxacin Injection
14 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA Recruiting NCT03246152 Phase 4 Bevacizumab
15 Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Recruiting NCT02665689 Phase 4 ranibizumab
16 Bromfenac Versus Dexamethasone After Cataract Surgery Active, not recruiting NCT03317847 Phase 4 Bromfenac 0.09 % Ophthalmic Solution;Dexamethasone 0.1% ophthalmic suspension
17 Effects of Ranibizumab to Delay or Regression Non-proliferative Diabetic Retinopathy(NPDR) With DME Assessed by Microaneurysm Changes: A Pilot Study Not yet recruiting NCT02834663 Phase 4 Lucentis
18 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Withdrawn NCT00304772 Phase 4 Fluconazole;Micafungin
19 Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis Unknown status NCT01768078 Phase 3
20 The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Unknown status NCT00012506 Phase 3 TNFR:Fc
21 Double-dose Ranibizumab for Polypoidal Choroidal Vasculopathy Unknown status NCT02769169 Phase 2, Phase 3 Lucentis® (Raibizumab) double-dose;Lucentis® (Raibizumab) regular-dose
22 Endophthalmitis Vitrectomy Study (EVS) Completed NCT00000130 Phase 3 Intravitreal Antibiotics
23 Clinical Trial of Eye Prophylaxis in the Newborn Completed NCT00000120 Phase 3 Erythromycin Ointment;Silver Nitrate Drops
24 Retaane® in Age-Related Macular Degeneration Completed NCT00569569 Phase 2, Phase 3 juxtascleral depot injection of Retaane
25 Systemic Avastin Therapy in Age-Related Macular Degeneration Completed NCT00531024 Phase 2, Phase 3 Bevacizumab;Sodium Chloride
26 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Completed NCT00942864 Phase 3 ranibizumab
27 Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis Completed NCT00884585 Phase 3 Cyclosporine Vehicle;Cyclosporine 0.010%
28 PRevention of Macular EDema After Cataract Surgery Completed NCT01774474 Phase 3 Bromfenac;Dexamethasone;Bevacizumab;Triamcinolone Acetonide
29 Efficacy and Tolerance Comparison Between Subconjunctival Injection of Triamcinolone and Intravitreal Implant of Dexamethasone for the Treatment of Inflammatory Macular Edema Recruiting NCT02556424 Phase 3 Dexamethasone;Triamcinolone
30 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Active, not recruiting NCT02307513 Phase 3 Apremilast (CC-10004);Placebo
31 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Not yet recruiting NCT03244072 Phase 2, Phase 3 Moxifloxacin;Placebo
32 Intracameral Antibiotic Safety Study Not yet recruiting NCT02590523 Phase 3 Vancomycin;Moxifloxacin;Placebo
33 Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. Terminated NCT02770729 Phase 3 Moxifloxacin;No injection of moxifloxacin
34 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3 Azithromycin plus chloroquine;sulfadoxine-pyrimethamine
35 A Study of the Safety, Tolerability, and Efficacy of IVT Pre-op 0.3mg Pegaptanib Sodium Versus Sham, for Management of Tractional Retinal Detachment and Vitreous Hemorrhage With Proliferative Diabetic Retinopathy Withdrawn NCT01589718 Phase 3 Macugen;Sham
36 Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty Unknown status NCT02424006 Phase 1, Phase 2
37 The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy Unknown status NCT00849537 Phase 1, Phase 2 Triamcinolone
38 Safety Study of 2.0mg Lucentis to Treat Polypoidal Choroidal Vasculopathy Unknown status NCT01469156 Phase 1, Phase 2 ranibizumab 0.5 or 2.0 mg/0.05 cc
39 Ranibizumab For Persistent Diabetic Macular Edema After Bevacizumab Unknown status NCT01845844 Phase 1, Phase 2 Ranibizumab 0.3mg/0.05cc
40 Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Unknown status NCT00349414 Phase 1, Phase 2
41 Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Completed NCT02595359 Phase 2 Moxifloxacin
42 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Completed NCT00001862 Phase 2 Enbrel
43 Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients Completed NCT00001311 Phase 2
44 Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Completed NCT00805233 Phase 2 combination ranibizumab + bromfenac;ranibizumab injection alone
45 Ranibizumab and Reduced Fluence PDT for AMD Completed NCT00527475 Phase 2 ranibizumab;verteporfin
46 Leflunomide to Treat Uveitis Completed NCT00001863 Phase 2 Leflunomide
47 20089 TA+Lucentis Combo Intravitreal Injections for Treatment of Neovascular Age-related Macular Degeneration (AMD) Completed NCT01175395 Phase 1, Phase 2 IBI-20089/Lucentis
48 Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00070759 Phase 2 Daclizumab
49 HAT in Eye Complications of Behcet's Disease Completed NCT00001865 Phase 2 Daclizumab
50 Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00043667 Phase 2 Daclizumab

Search NIH Clinical Center for Endophthalmitis

Cochrane evidence based reviews: endophthalmitis

Genetic Tests for Endophthalmitis

Anatomical Context for Endophthalmitis

MalaCards organs/tissues related to Endophthalmitis:

41
Eye, Endothelial, Liver, Testes, Thyroid, Lung, Retina

Publications for Endophthalmitis

Articles related to Endophthalmitis:

(show top 50) (show all 895)
# Title Authors Year
1
Acanthamoeba endophthalmitis during treatment for cutaneous disease in a renal transplant patient. ( 29359845 )
2018
2
Post-surgical versus post-intravitreal injection endophthalmitis: changing patterns in causative flora. ( 29931722 )
2018
3
Streptococcus Dysgalactiae Subspecies Equisimilis Endogenous Endophthalmitis Associated with Aortic Valve Abscess. ( 29969334 )
2018
4
Stromal Keratitis with Endophthalmitis Caused by Vittaforma Corneae in an Immunocompetent Patient: A Case Report. ( 29672246 )
2018
5
Postsurgical Cataract Prophylaxis With Intravitreal "Triamcinolone-Moxifloxacin" May Not Be Optimal For Preventing Endophthalmitis. ( 29944493 )
2018
6
Surgical preferences in the management of recalcitrant endophthalmitis. ( 29300514 )
2018
7
Epidemiology and Mortality-Related Prognostic Factors in Endophthalmitis. ( 29847653 )
2018
8
Change in Nationwide Incidence of Post-Cataract Surgery Endophthalmitis: Korean Cohort Study from 2002 to 2013. ( 29953316 )
2018
9
Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis. ( 29844284 )
2018
10
Endophthalmitis in patients co-infected by HIV and sporotrichosis: a systematic review of published case reports. ( 29880916 )
2018
11
Antibiotic prophylaxis for preventing endophthalmitis after intravitreal injection: a systematic review. ( 29891901 )
2018
12
Endogenous <i>Cryptococcus neoformans</i> endophthalmitis with subretinal abscess in a HIV-infected man. ( 29941759 )
2018
13
Endophthalmitis Following XEN Stent Exposure. ( 29952822 )
2018
14
The Routine Use of Intracameral Antibiotics to Prevent Endophthalmitis After Cataract Surgery: How Good is the Evidence? ( 29974362 )
2018
15
Human Endophthalmitis Caused By Pseudorabies Virus Infection, China, 2017. ( 29774834 )
2018
16
Management of <i>Candida glabrata</i> infectious crystalline keratopathy with endophthalmitis following penetrating keratoplasty. ( 29941758 )
2018
17
Trends in treatment strategies for suspected bacterial endophthalmitis. ( 29417214 )
2018
18
Endophthalmitis caused by Purpureocillium lilacinum. ( 29366691 )
2018
19
Incidence and characteristics of acute-onset postoperative bacterial and sterile endophthalmitis in dogs following elective phacoemulsification: 1,447 cases (1995-2015). ( 29963957 )
2018
20
Another perspective on the treatment of postoperative endophthalmitis: Unclear evidence for the role of vitrectomy. ( 29862645 )
2018
21
Endophthalmitis and Mycotic Aneurysm: The Only Clues to Underlying Endocarditis. ( 29849250 )
2018
22
Endophthalmitis following Strabismus Surgery: IPOSC Global Study. ( 29966454 )
2018
23
XEN Implant-Related Endophthalmitis. ( 29389405 )
2018
24
A British Ophthalmological Surveillance Unit Study on metastatic endogenous endophthalmitis. ( 29328066 )
2018
25
Pediatric Infectious Endophthalmitis: A Case Series. ( 29378081 )
2018
26
Is combined cataract surgery associated with acute postoperative endophthalmitis? A nationwide study from 2005 to 2014. ( 29925513 )
2018
27
Exophiala dermatitidis Endophthalmitis: Case Report and Literature Review. ( 29374798 )
2018
28
A cluster of nontuberculous mycobacterial endophthalmitis (NTME) cases after cataract surgery: clinical features and treatment outcomes. ( 29844367 )
2018
29
Late-onset postoperative Mycobacterium haemophilum endophthalmitis masquerading as inflammatory uveitis: a case report. ( 29415658 )
2018
30
Bacteriology and cefuroxime-resistance in endophthalmitis following cataract surgery before and after the introduction of prophylactic intracameral cefuroxime: a retrospective single-centre study. ( 29432821 )
2018
31
Incidence of Endophthalmitis after Intravitreal Injections: Risk Factors, Microbiology Profile, and Clinical Outcomes. ( 29437495 )
2018
32
Incidence, microbiology, and outcomes of endophthalmitis after 111,876 pars plana vitrectomies at a single, tertiary eye care hospital. ( 29338030 )
2018
33
Incidence of endophthalmitis after 23-gauge pars plana vitrectomy. ( 29361927 )
2018
34
INCIDENCE OF ENDOPHTHALMITIS AFTER VITRECTOMY: A Systematic Review and Meta-analysis. ( 29370034 )
2018
35
Diagnostic performance of blood culture bottles for vitreous culture compared to conventional microbiological cultures in patients with suspected endophthalmitis. ( 29318458 )
2018
36
Endophthalmitis Following Pediatric Cataract Surgery: An International Pediatric Ophthalmology and Strabismus Council Global Perspective. ( 28991343 )
2018
37
Candida Endophthalmitis After Descemet Stripping Automated Endothelial Keratoplasty With Grafts From Both Eyes of a Donor With Possible Systemic Candidiasis. ( 29303885 )
2018
38
Prevalence of, and risk factors for, hematogenous fungal endophthalmitis in patients with Candida bloodstream infection. ( 29959658 )
2018
39
Utility of MALDI-TOF mass spectrometry in an outbreak investigation of acute endophthalmitis following intravitreal injection. ( 29605188 )
2018
40
BETA-D-GLUCAN TESTING IN PATIENTS WITH FUNGAL ENDOPHTHALMITIS. ( 29370030 )
2018
41
Successful management of bee sting induced <i>Aspergillus fumigatus</i> endophthalmitis and scleritis. ( 29480270 )
2018
42
Gas gangrene of the eye: endogenous &amp;lt;em&amp;gt;Clostridium perfringens&amp;lt;/em&amp;gt; endophthalmitis. ( 29385972 )
2018
43
Presumably contaminated intravenous infusion-induced <i>Aspergillus terreus</i> endogenous endophthalmitis presenting with posterior hypopyon. ( 29582833 )
2018
44
Successful treatment of fungal endophthalmitis using intravitreal caspofungin. ( 28832730 )
2017
45
Comment on &amp;quot;Surgical management of fungal endophthalmitis resulting from fungal keratitis&amp;quot;. ( 28944212 )
2017
46
Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China. ( 28884023 )
2017
47
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993282 )
2017
48
Optical Coherence Tomography Findings in Endogenous Fungal Chorioretinitis, Retinitis, and Endophthalmitis. ( 29121358 )
2017
49
Comparison of methods for identifying causative bacterial microorganisms in presumed acute endophthalmitis: conventional culture, blood culture, and PCR. ( 28222703 )
2017
50
Acute Endophthalmitis Caused by<i>Leuconostoc</i>spp. following Intravitreal Bevacizumab Injection. ( 29282402 )
2017

Variations for Endophthalmitis

Expression for Endophthalmitis

Search GEO for disease gene expression data for Endophthalmitis.

Pathways for Endophthalmitis

GO Terms for Endophthalmitis

Cellular components related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.26 HMGB1 ICAM1 PLG VEGFA
2 extracellular space GO:0005615 9.1 DEFB1 HMGB1 ICAM1 PLG SELE VEGFA

Biological processes related to Endophthalmitis according to GeneCards Suite gene sharing:

(show all 11)
# Name GO ID Score Top Affiliating Genes
1 innate immune response GO:0045087 9.67 CARD9 DEFB1 HMGB1 OPTN
2 positive regulation of interleukin-6 production GO:0032755 9.49 CARD9 HMGB1
3 positive regulation of blood vessel endothelial cell migration GO:0043536 9.48 HMGB1 VEGFA
4 positive regulation of tumor necrosis factor production GO:0032760 9.46 CARD9 HMGB1
5 positive chemotaxis GO:0050918 9.43 HMGB1 VEGFA
6 ovarian follicle development GO:0001541 9.4 ICAM1 VEGFA
7 leukocyte cell-cell adhesion GO:0007159 9.32 ICAM1 SELE
8 positive regulation of sprouting angiogenesis GO:1903672 9.26 HMGB1 VEGFA
9 positive regulation of innate immune response GO:0045089 9.16 CARD9 HMGB1
10 positive regulation of receptor internalization GO:0002092 8.96 SELE VEGFA
11 endothelial cell chemotaxis GO:0035767 8.62 HMGB1 VEGFA

Molecular functions related to Endophthalmitis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 chemoattractant activity GO:0042056 8.62 HMGB1 VEGFA

Sources for Endophthalmitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....